home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

32.22 -0.16 (-0.49%)

Streaming Delayed Price Updated: 1:22 PM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

29 30 Next >

Here's Why Shares in Viking Therapeutics Crashed This Week ↗

August 22, 2025

The phase 2 trial results for its key drug didn't pan out quite as planned.

Via The Motley Fool

Market Brief: After Viking Therapeutics’ Results, Is Entera Bio the Oral Platform Play to Watch? (NASDAQ: ENTX)

August 22, 2025

Via AB Newswire

Is Beaten-Down Viking Therapeutics Stock a Buy on the Dip? ↗

August 21, 2025

A disappointing result for its oral obesity candidate hammered the stock price.

Via The Motley Fool

Here's Why Viking Therapeutics Bounced Back Today ↗

August 20, 2025

Viking's key drug demonstrated excellent body weight reduction data in a phase 2 trial, but its safety and tolerability data were disappointing.

Via The Motley Fool

Wall Street Defends Viking As Weight Loss Pill Trial Results Trigger Stock Rout; Retail Calls Selloff ‘Unjustified’ ↗

August 19, 2025

Via Stocktwits

Intel, Palantir, Home Depot, Viking, Nio: Stocks Making The Biggest Moves Today ↗

August 19, 2025

Via Stocktwits

This Drugmaker Stock Slumped 36% In Tuesday’s Premarket Session: Here’s Why ↗

August 19, 2025

Via Stocktwits

Under Pressure: Palantir and Viking Therapeutics Face Investor Scrutiny

August 20, 2025

The financial markets are a dynamic arena where fortunes can shift rapidly, and the past week has seen two prominent companies, Palantir Technologies Inc. (NYSE: PLTR) and Viking Therapeutics (NASDAQ:...

Via MarketMinute

Topics Artificial Intelligence

Viking's 42% Plunge Splits Experts—A '$129 Strong Buy' Or 'Clearly Inferior' Drug? ↗

August 20, 2025

Viking (VKTX) stock plunged 42% after its obesity pill trial. Experts are split: some call it a $129 Strong Buy, others say it's inferior.

Via Benzinga

Viking Therapeutics Plummets as Oral Obesity Drug Trial Raises Tolerability Concerns

August 19, 2025

San Diego, CA – Viking Therapeutics (NASDAQ: VKTX) experienced a dramatic stock decline today following the release of disappointing clinical trial results for its highly anticipated oral tablet...

Via MarketMinute

Palantir, AMD, Oracle, Viking And Nvidia: Why These 5 Stocks Are On Investors' Radars Today ↗

August 19, 2025

U.S. stock indices closed mixed on Tuesday, with the Dow Jones Industrial Average edging up 0.02% to 44,922.27.

Via Benzinga

Topics Stocks

Which stocks are experiencing notable movement on Tuesday? ↗

August 19, 2025

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.

Via Chartmill

Viking Obesity Pill Faces Steep Climb Against Lilly's Tirzepatide, Analyst Calls Downtrend Reaction 'Extreme' ↗

August 19, 2025

Viking shares fell on Phase 2 obesity pill data as tolerability issues surfaced, but William Blair says the stock's sell-off is excessive.

Via Benzinga

Tech Stocks Drop, Palantir Plunges Over 8%: What's Moving Markets Tuesday? ↗

August 19, 2025

Tech stocks pulled back on Tuesday as the absence of fresh bullish catalysts prompted investors to take profits after the recent months-long rally.

Via Benzinga

Nasdaq Down Over 300 Points; Medtronic Posts Upbeat Earnings ↗

August 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 19, 2025

Via Benzinga

These stocks are moving in today's session ↗

August 19, 2025

Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.

Via Chartmill

Why Novo Nordisk Stock Popped Today ↗

August 19, 2025

For a cheap GLP-1 weight loss stock like Novo Nordisk, almost any news can help the stock pop.

Via The Motley Fool

Why Viking Therapeutics Stock Crashed Today ↗

August 19, 2025

Viking's new GLP-1 weight loss pill is pretty great -- but is it enough to turn the company profitable?

Via The Motley Fool

US Stocks Mixed; Home Depot Shares Gain After Q2 Results ↗

August 19, 2025

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

August 19, 2025

The market is filled with gapping stocks in Tuesday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Via Chartmill

Like Eli Lilly, Viking Therapeutics' Oral Weight Loss Drug Disappoints, Stock Tanks ↗

August 19, 2025

Viking Therapeutics reported positive Phase 2 results for VK2735, showing significant weight loss and safety in obesity patients versus placebo.

Via Benzinga

Viking Therapeutics Crashes 35% On Mixed Results For Its Weight-Loss Pill ↗

August 19, 2025

Shares lost more than a third of their value after Viking unveiled mixed results for its oral VK2735.

Via Investor's Business Daily

Tuesday's pre-market session: top gainers and losers ↗

August 19, 2025

Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 19, 2025

Via Benzinga

Stock Market Today: S&P 500 Slips, Dow Futures Rise—Intel, Palo Alto, Home Depot In Focus ↗

August 19, 2025

U.S. stock futures were fluctuating on Tuesday following mostly unchanged moves from Monday. Futures of major benchmark indices were mixed.

Via Benzinga

Topics Stocks

Eli Lilly Considering Viking Therapeutics Acquisition? Expert Says 'They're Setting Up For Something BIG' As LLY Issues 40-Year Bond ↗

August 19, 2025

Eli Lilly's rare 40-year bond sparks talk of a Viking Therapeutics (VKTX) acquisition. Experts say LLY is "setting up for something BIG."

Via Benzinga

Topics Bonds

Predicting the Next Rule Breaker Buyout ↗

August 19, 2025

Having a stock you own get acquired at a premium feels good at first, but what about the long-term gains that will be left behind when your chips are off the table?

Via The Motley Fool

Topics Artificial Intelligence

Why Viking Therapeutics Stock Zoomed 5% Higher Today ↗

August 18, 2025

The company is a front-runner in the race to develop an orally administered weight loss drug.

Via The Motley Fool

Profusa Inc (NASDAQ: PFSA) Establishes a distributor partner in Spain for Lumee Oxygen platform

August 18, 2025

Via AB Newswire

< Previous 1 2 3 4 5 6 7 8 9

...

29 30 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com